Gulf International Bank UK Ltd acquired a new stake in Revvity, Inc. (NYSE:RVTY – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 10,395 shares of the company’s stock, valued at approximately $1,136,000.
A number of other hedge funds also recently made changes to their positions in RVTY. Gladius Capital Management LP increased its position in shares of Revvity by 84.1% during the 3rd quarter. Gladius Capital Management LP now owns 232 shares of the company’s stock worth $26,000 after purchasing an additional 106 shares in the last quarter. Headinvest LLC acquired a new stake in shares of Revvity during the 3rd quarter worth about $57,000. DB Wealth Management Group LLC acquired a new stake in shares of Revvity during the 4th quarter worth about $79,000. Sugarloaf Wealth Management LLC acquired a new stake in shares of Revvity during the 4th quarter worth about $168,000. Finally, First Hawaiian Bank acquired a new stake in shares of Revvity during the 4th quarter worth about $219,000. Institutional investors and hedge funds own 82.63% of the company’s stock.
Insider Buying and Selling
In related news, insider Prahlad R. Singh sold 21,217 shares of Revvity stock in a transaction that occurred on Monday, February 5th. The shares were sold at an average price of $104.28, for a total transaction of $2,212,508.76. Following the transaction, the insider now owns 92,801 shares of the company’s stock, valued at approximately $9,677,288.28. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.52% of the stock is owned by insiders.
Wall Street Analyst Weigh In
A number of equities research analysts recently issued reports on the stock. Barclays increased their target price on shares of Revvity from $92.00 to $105.00 and gave the stock an “equal weight” rating in a research report on Thursday, January 25th. UBS Group lowered shares of Revvity from a “buy” rating to a “neutral” rating and increased their price objective for the stock from $105.00 to $125.00 in a report on Tuesday, January 16th. Evercore ISI raised shares of Revvity from an “in-line” rating to an “outperform” rating and increased their price objective for the stock from $88.00 to $125.00 in a report on Thursday, January 4th. Wells Fargo & Company assumed coverage on shares of Revvity in a report on Tuesday, December 19th. They set an “equal weight” rating and a $95.00 price objective on the stock. Finally, Stifel Nicolaus increased their price objective on shares of Revvity from $95.00 to $110.00 and gave the stock a “hold” rating in a report on Friday, February 2nd. Six research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $118.91.
Get Our Latest Stock Analysis on RVTY
Revvity Stock Down 1.7 %
Shares of NYSE RVTY opened at $103.25 on Friday. The firm has a market capitalization of $12.75 billion, a PE ratio of 18.77, a price-to-earnings-growth ratio of 2.73 and a beta of 1.10. The company has a current ratio of 2.07, a quick ratio of 1.77 and a debt-to-equity ratio of 0.40. Revvity, Inc. has a 1 year low of $79.50 and a 1 year high of $139.04. The firm’s 50-day moving average is $106.06 and its 200-day moving average is $102.48.
Revvity (NYSE:RVTY – Get Free Report) last issued its earnings results on Thursday, February 1st. The company reported $1.25 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.15 by $0.10. The company had revenue of $695.90 million for the quarter. Revvity had a net margin of 25.20% and a return on equity of 7.41%. Equities analysts expect that Revvity, Inc. will post 4.65 EPS for the current year.
Revvity Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 10th. Investors of record on Friday, April 19th will be paid a dividend of $0.07 per share. This represents a $0.28 annualized dividend and a yield of 0.27%. The ex-dividend date is Thursday, April 18th. Revvity’s payout ratio is 5.09%.
Revvity Company Profile
Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.
Further Reading
Want to see what other hedge funds are holding RVTY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Revvity, Inc. (NYSE:RVTY – Free Report).
Receive News & Ratings for Revvity Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Revvity and related companies with MarketBeat.com’s FREE daily email newsletter.
